One Good Thing: All 14 Patients in Experimental Trial Saw Cancer Go Into Remission

What's being called an unprecedented breakthrough in cancer treatment recently completed a small trial at New York City's Memorial Sloan Kettering in 14 rectal cancer patients. The experimental trial with the drug dostarlimab resulted in 100 percent remission in all candidates, precluding the need for chemotherapy or surgery. Cheddar News anchor Hena Doba dives into this hopeful story.

Jun 17, 2022

More Videos

Inside Day One From The Paris Olympics!

Olympic Gold Medalist & USA Diving Coach David Boudia reveals what we can expect from the 2024 Paris Olympics. Watch!

Exclusive Look At The 2024 Olympics "Anti-Sex" Beds

Airweave's CEO & COO talk bringing their "anti-sex" beds to the Olympic village, AI-driven mattress technology, and competing in the US market

Domino's Q2: Strong Growth Amidst Inflation and Future Challenges

Domino’s Pizza reported a 7.1% revenue rise to $1.1B amid value meal competition and inflation. Q3 may slow, with caution on growth and consumer spending.

How Salesforce AI Is Revolutionizing Customer Service

Find out how Salesforce AI's customer service agent, Einstein, is changing the way you will get the answers you need. Watch!

Celebrating National Tequila Day With The Rock's Teremana Tequila

Teremana CEO Richard Black, gives us an inside look at how the spirits brand is expanding into the global market.

Which Sports People Want To Place Bets On At The Olympics

Max Bichsel from Gambling.com Group explains how people are getting into the gambling game for the 2024 Paris Olympics.

Inside The Preparation For The 2024 Paris Olympics

Find out what goes in to preparing for the 2024 Paris Olympics from NBCUniversal CMO Jenny Storms. Watch!

401(k) Evolution: Record High Savings Through Automatic Enrollment

Vanguard's "How America Saves" report analyzes U.S. retirement trends, focusing on 401(k) plans, including automatic enrollment and contribution rates.

Trending Now